Measurement of activated factor XII in health and disease

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 5, 1996, Pages 530-535

  Coppola, R ^a   Cristilli, P ^a   Cugno, M ^b   Ariens R A S ^a   Mari, D ^b   Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Aging; C1 inhibitor deficiency; Contact activation; Factor XII; Pregnancy; Sepsis; Thrombolysis

Indexed keywords

BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C1S INHIBITOR;

ADULT; AGED; AGING; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL;

EID: 0029835742     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199607000-00004     Document Type: Article

References (34)

1. Colman RW. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun 1969; 35: 273-279.
2. Mandle RJ, Kaplan AP. Hageman factor-dependent fibrinolysis. Generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood 1979; 54: 850-862.
3. Cooper NR, Miles LA, Griffin JH. Effect of plasma kallikrein and plasmin on the first component of complement. J Immunol 1980; 124: 1517-1524.
4. Ghebrehiwet B, Randazzo BP, Dunn JT, Kaplan AP. Mechanism of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest 1983; 71: 1450-1456.
5. Wiggins RC. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein. J Biol Chem 1983; 258: 8963-8970.
6. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15.
7. DeLa Cadena RA, Wachtfogel YT, Colman RW. Contact activation pathway: inflammation and coagulation. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, PA: J.B. Lippincott Company, 1994: 219-240.
8. Mandle R Jr, Kaplan AP. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in Hageman factor-dependent fibrinolysis. J Biol Chem 1977; 252: 6097-6104.
9. Revak SD, Cochrane CG, Bouma BN, Griffin JH. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma. J Exp Med 1978; 147: 719-729.
10. de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M. Inactivation of factor XII active fragment in normal plasma. Predominant role of C1-inhibitor. J Clin Invest 1984; 73: 1542-1549.
11. Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol 1988; 6: 595-628.
12. Boisclair MD, Lane DA, Philippou H, et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350-3357.
13. Ford RP, Esnouf MP, Burgess AI, Sarphie A. An enzyme linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman Factor) in human plasma. J Immunoassay 1996; 17: 119-131.
14. 2-macroglobulin-kallikrein complexes detect contact system activation in hereditary angioedema and human sepsis. Blood 1991; 77: 2660-2667.
15. Schmaier AH, Farber A, Schein R, Sprung C. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. J Lab Clin Med 1988; 112: 182-192.
16. Nuijens JH, Huijbregts CCM, Eerenberg-Belmer AJM, et al. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 1988; 72: 1841-1848.
17. Berrettini M, Lämmle B, White T, et al. Detection of in vitro and in vivo cleavage of high molecular weight kininogen in human plasma by immunoblotting with monoclonal antibodies. Blood 1986; 68: 455-462.
18. Chhibber G, Cohen A, Lane S, Farber A, Meloni FJ, Schmaier AH. Immunoblotting of plasma in a pregnant patient with hereditary angioedema. J Lab Clin Med 1990; 115: 112-121.
19. Cugno M, Hack CE, de Boer JP, Eerenberg AJM, Agostoni A, Cicardi M. Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med 1993; 121: 38-43.
20. Mitropoulos KA, Martin JC, Burgess AI, et al. The increased rate of activation of factor XII in late pregnancy can contribute to the increased reactivity of factor VII. Thromb Haemost 1990; 63: 349-355.
21. Agostoni A, Cardinali M, Frangi D, et al. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator. Circulation 1994; 90: 2666-2670.
22. Lighart GJ, Corberand JX, Fournier C, et al. Admission criteria for immunogerontological studies in man: The Senieur Protocol. Med Ageing Dev 1984; 28: 47-55.
23. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 1992; 20: 864-874.
24. Ostermann H, Rothenburger M, Mester RM, van de Loo J, Kienast J. Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy. Br J Haematol 1994; 88: 332-337.
25. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of the coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68.
26. Merlini PA, Bauer KA, Oltrona L, et al. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. JACC 1995; 25: 203-209.
27. Ariens RAS, Coppola R, Potenza I, Mannucci PM. The increase with age of the components of the tissue factor coagulation pathway is gender-dependent. Blood Coag Fibrinol 1995; 6: 433-437.
28. Radcliffe R, Bagdasarian A, Colman RW, Nemerson Y. Activation of factor VII by Hageman factor fragments. Blood 1977; 50: 611-621.
29. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995; 11: 3144-3149.
30. Ewald GA, Eisenberg PR. Plasmin-mediated activation of the contact system in response to pharmacological thrombolysis. Circulation 1993; 91: 29-36.
31. Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW. Effect of heparin on the activation of factor XII and the contact system in plasma. Thromb Haemost 1991; 66: 540-547.
32. Carvalho AC, DaMarinis S, Scott CF, Silver LD, Schmaier AH, Colman RW. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 1988; 112: 270-277.
33. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema. Am J Med 1963; 35: 37-44.
34. Cugno M, Nuijens J, Hack E, et al. Plasma levels of C1 inhibitor complexes and cleaved C1 inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1990; 85: 1215-1220.